Relationship Between Anemia, B-Type Natriuretic Peptide Level and Physical Functioning in Heart Failure

Volume: 24 Number: 2 March 5, 2015
Derya Atik , Hilal Kuşçu Karatepe
EN TR

Relationship Between Anemia, B-Type Natriuretic Peptide Level and Physical Functioning in Heart Failure

Abstract

Heart failure is a complex clinical condition caused by structural or functional changes affecting the dilatation and/or ejection ability of the ventricle. Anemia and B-type natriuretic peptide (BNP) levels are commonly observed conditions in heart failure, affecting quality of life, physical functioning, mortality, and morbidity. In cases with heart failure, it is important that nurses and other healthcare personnel closely monitor anemia and BNP values that are closely associated with functional capacity. This article focuses on the association between heart failure and anemia and BNP level, and its effect on physical function, considering that the results will provide guidance for nurses and healthcare professionals in patient monitoring, treatment and care planning.

Keywords

Heart Failure, Anemia, Type B natriüretik peptide, Nursing

References

  1. Abete P, Testa G, Della-Morte D, Gargiulo G, Galizia G, de Santis D et al. Treatment for chronic heart failure in the elderly: current practice and problems. Heart Fail Rev. 2013;18:529-51.
  2. Değertekin M, Erol C, Ergene O, Tokgözoğlu L, Aksoy M, Erol MK et al. Heart failure prevalence and predictors in Turkey (HAPPY) çalışması. Turk Kardiyol Dern Ars. 2012;40:298-308.
  3. Sata Y, Krum H. The future of pharmacological therapy for heart failure. Circ J. 2010;74:809-17.
  4. Anker SD, John M, Pedersen PU, Raguso C, Cicoira M, Dardai E et al. ESPEN Guidelines on enteral nutrition: Cardiology and pulmonology. Clin Nutr. 2006;25:311-8.
  5. Flynn KE, Pina IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ et al. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1451-9.
  6. Carels RA, Musher-Eizenman D, Cacciapaglia H, Perez-Benitez CI, Christie S, O'Brien W. Psychosocial functioning and physical symptoms in heart failure patients: a within-individual approach. J Psychosom Res. 2004;56:95-101.
  7. Dixon T, Lim LL, Powell H, Fisher JD. Psychosocial experiences of cardiac patients in early recovery: a community-based study. J Adv Nurs. 2000;31:1368-75.
  8. Murberg TA, Bru E, Aarsland T, Svebak S. Social support, social disability and their role as predictors of depression among patients with congestive heart failure. Scand J Soc Med. 1998;26:87-95.
  9. Maisel A. B type natriuretic peptide in the diagnosis and management of congestive heart failure. Cardiol Clinics. 2001;19:557-71.
  10. Wieczorek SJ, Bailly KR, Thomas P, Wu AHB, Hager D, Ferrier A et al. Clinical evaluation of the Triage B type natriuretic peptide assay for point of core testing of patients with congestive heart failure. Clin Chem. 2000;46:A77.
AMA
1.Atik D, Kuşçu Karatepe H. Relationship Between Anemia, B-Type Natriuretic Peptide Level and Physical Functioning in Heart Failure. Arşiv Kaynak Tarama Dergisi. 2015;24(2):171-181. doi:10.17827/aktd.37933